High-Sensitivity C-Reactive Protein Is Within Normal Levels at the Very Onset of First ST-Segment Elevation Acute Myocardial Infarction in 41% of Cases: A Multiethnic Case-Control Study

This study sought to assess the prevalence of normal levels of high sensitivity C-reactive protein (hsCRP) at the very onset of ST-segment elevation myocardial infarction (STEMI). Levels of hsCRP ≥2 mg/l identify individuals who benefit from lipid lowering and possibly anti-inflammatory agents, but...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2011-12, Vol.58 (25), p.2654-2661
Hauptverfasser:	CRISTELL, Nicole, CIANFLONE, Domenico, DE METRIO, Monica, MORETTI, Luciano, HUI LI, UREN, Neal G, DAYI HU, MASERI, Attilio, DURANTE, Alessandro, AMMIRATI, Enrico, VANUZZO, Diego, BANFI, Michela, CALORI, Giliola, LATIB, Azeem, CREA, Filippo, MARENZI, Giancarlo
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndromes Age Aged Apolipoproteins Biological and medical sciences C-Reactive Protein - analysis Cardiology Cardiology. Vascular system Cardiovascular disease Case-Control Studies Coronary heart disease Diabetes Electrocardiography Female Heart Heart attacks Humans Hypertension Male Medical sciences Middle Aged Myocardial Infarction - blood Myocardial Infarction - diagnosis Myocardial Infarction - ethnology Myocarditis. Cardiomyopathies Predictive Value of Tests Prevalence Proteins Shipments Smoking
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This study sought to assess the prevalence of normal levels of high sensitivity C-reactive protein (hsCRP) at the very onset of ST-segment elevation myocardial infarction (STEMI). Levels of hsCRP ≥2 mg/l identify individuals who benefit from lipid lowering and possibly anti-inflammatory agents, but how many patients develop infarction in spite of hsCRP levels
ISSN:	0735-1097 1558-3597
DOI:	10.1016/j.jacc.2011.08.055